The report highlights that e-cigarettes can play a critical role in transitioning generations of adult cigarette smokers to reduced-risk nicotine products
Press Release, 28th December 2022: RELX International, a responsible multinational electronic cigarettes company, praises the findings of a new research compiled by Cochrane1. The international network of researchers, that produce high quality literature reviews, has found ‘high-certainty’ evidence in support of vaping for smoking cessation.
Cochrane is a registered not-for-profit organisation, with a global independent network of members from over 190 countries that gathers and summarises evidence from research to help make people make informed decisions about their health.
The Cochrane Library summarises and interprets scientific and medical research to produce reviews and meta-analyses of key scientific questions that are considered the ‘gold standard’ in the medical profession. The review, which is aimed at examining the effectiveness, admissibility, and safety of e-cigarettes to help those who smoke quit, includes 78 studies representing 22,052 participants. Forty of those studies are randomised control trials.
Key findings and conclusions from the Cochrane Review are summarised below:
- There is ‘high-certainty evidence’ that nicotine-containing e-cigarettes increase the chance of an adult smoker achieving long-term cessation compared to traditional Nicotine Replacement Therapy’s (NRT) – such as the use of nicotine patches or gums.
- Per 100 people who attempt to quit, e-cigarettes may be expected to yield an additional four quitters compared to traditional NRT users.
- Evidence also suggests that nicotine e-cigarettes may benefit someone attempting to quit smoking better than behavioural support, although the researchers concluded it is less certain.
- Researchers did not detect evidence of ‘serious harm’ from e-cigarettes.
RELX International’s Robert Naouss, External Affairs Director – MENA & Europe said: “This comprehensive evidence review confirms, once again, that e-cigarettes, while not risk free, can play a critical role in transitioning generations of adult cigarette smokers to reduced-risk nicotine products; and that high quality e-cigarette products, like those within our RELX portfolio, are more effective than medically licensed NRTs. To that effect, we proudly continue our commitment to putting only quality products in the hands of adult smokers, by investing in state-of-the-art facilities and scientific testing that sees each product go through 195 quality checks before it hits the market.”
Cochrane’s concrete findings follow several recent reviews in the UK2, Canada3 and New Zealand4 of the harms of e-cigarettes, with each showing clear evidence that vaping poses only a small fraction of the health risks of smoking. Taken altogether, these reports should provide reassurance to adult smokers that e-cigarettes are a better alternative and can increase your chances of quitting traditional smoking. Plus, by not burning tobacco, e-cigarettes do not expose users to the same complex mix of chemicals as conventional combustible cigarettes do.
As a growing body of evidence emerges in support of e-cigarettes, it becomes even more crucial that policymakers and regulators, as well as scientific experts, rethink the role (and use) of e-cigarettes in the fight against tobacco smoking by providing adult smokers with proven tools to quit smoking.
Sources:
- Full Cochrane review 2022: https://www.cochrane.org/news/latest-cochrane-review-finds-high-certainty-evidence-nicotine-e-cigarettes-are-more-effective
- UK Government updated reports 2022: https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update/nicotine-vaping-in-england-2022-evidence-update-main-findings
- Government of Canada vaping and quitting smoking reports: https://www.canada.ca/en/health-canada/services/smoking-tobacco/vaping/smokers.html
- New Zealand Ministry of Health vaping facts: https://vapingfacts.health.nz/
RELX International
Founded in 2019, RELX International is a multinational electronic cigarettes company that markets and sells RELX, The World’s Advanced vape brand powered by SuperSmoothTM technology. RELX, Asia’s leading e-cigarette brand, is widening its footprint across the world, it is currently available in 40+ countries such as the UK, France, Italy, Germany, Indonesia, Philippines, Canada, KSA and the UAE. What sets RELX apart from competition is the fact that it has a full ecosystem (such as closed pods, disposables, device, and power bank accessories) that are designed at a cutting-edge research and development center and produced at one of the world’s largest e-cigarette factories. RELX’s mission is to make RELX a trusted brand for legal age adult smokers through state-of-the-art products, industry-leading technologies, and scientific advances in collaboration with talented and committed people around the globe. The company has attracted global talents from Uber, Procter & Gamble, Apple, Beats, and L’Oréal. RELX is proud to be listed in Dubai Duty Free, the first duty free channel in the world.